| 摘要 |
Provided is a nasal pharmaceutical formulation comprising fluticasone. In a preferred embodiment the formulation comprises fluticasone propionate, microcrystalline cellulose, sodium carboxymethylcellulose, disodium edetate, polysorbate 80, glycerol and one or more of benzalkonium chloride or phenylethyl alcohol, wherein the formulation is adapted to be applied as droplets and half of the droplets in the administered dose unit are between 75um and 95 um in size. The formulation may be useful for the prophylaxis or treatment of seasonal or perennial allergic and non-allergic rhinitis, and rhinoconjunctivitis. |
